ArticleRheumatology advances in practice2023
Nintedanib for progressive fibrosing interstitial lung disease: how many meet criteria in a UK district general hospital systemic sclerosis cohort?
Gen Nen Ho et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.